张新军
作者单位：610041 成都，四川大学华西医院老年医学中心 国家老年疾病临床医学研究中心(四川大学华西医院)，四川省老年疾病临床医学研究中心
通信作者：张新军，电子信箱：alexzhang34@163.com
引用本文：
张新军. 《中国高血压防治指南(2024年修订版)》新增内容解读——以改善血压变异和降压目标范围内时间为核心的高质量降压策略浅析[J]. 中国心血管杂志, 2024, 29(5): 396-399. DOI: 10.3969/j.issn.1007-5410.2024.05.002.
参考文献
[1] 中国高血压防治指南修订委员会, 高血压联盟(中国),中国医疗保健国际交流促进会高血压病学分会, 等. 中国高血压防治指南(2024年修订版)[J]. 中华高血压杂志(中英文), 2024, 32(7): 603-700.
[2] Wang Z, Chen Z, Zhang L, et al; China Hypertension Survey Investigators. Status of hypertension in China: results from the China hypertension survey, 2012-2015[J]. Circulation, 2018, 137(22): 2344-2356.
[3] Hansen TW, Thijs L, Li Y, et al; International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes Investigators. Prognostic value of reading-to-reading blood pressure variability over 24 hours in 8938 subjects from 11 populations[J]. Hypertension, 2010, 55(4): 1049-1057.
[4] Rothwell PM, Howard SC, Dolan E, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension[J]. Lancet, 2010, 375(9718): 895-905.
[5] Hermida RC, Crespo JJ, Domínguez-Sardiña M, et al. Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial[J]. Eur Heart J, 2020, 41(48): 4565-4576.
[6] Khong TK, Lin GS. What does the TIME study tell us about morning and evening dosing of antihypertensive medication？[J]. Drug Ther Bull, 2023, 61(4): 52-54.
[7] Mancia G, Kreutz R, Brunström M, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA)[J]. J Hypertens, 2023, 41(12): 1874-2071.
[8] Kollias A, Kyriakoulis KG, Stambolliu E, et al. Seasonal blood pressure variation assessed by different measurement methods: systematic review and meta-analysis[J]. J Hypertens, 2020, 38(5): 791-798.
[9] Kario K, Pickering TG, Umeda Y, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study[J]. Circulation, 2003, 107(10): 1401-1406.
[10] Yasuoka S, Kai H, Kajimoto H, et al. Blood pressure variability activates cardiac mineralocorticoid receptor and induces cardiac remodeling in hypertensive rats[J]. Circ J, 2013, 77(6): 1474-1481.
[11] Tao X, Zhang SH, Shen FM, et al. High-level apoptosis is persistent in myocardiocytes of sinoaortic-denervated rats[J]. J Hypertens, 2004, 22(3): 557-563.
[12] Aoki Y, Kai H, Kajimoto H, et al. Large blood pressure variability aggravates arteriolosclerosis and cortical sclerotic changes in the kidney in hypertensive rats[J]. Circ J, 2014, 78(9): 2284-2291.
[13] Rothwell PM, Howard SC, Dolan E, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension[J]. Lancet, 2010, 375(9718): 895-905.
[14] Mallamaci F, Minutolo R, Leonardis D, et al. Long-term visit-to-visit office blood pressure variability increases the risk of adverse cardiovascular outcomes in patients with chronic kidney disease[J]. Kidney Int, 2013, 84(2): 381-389.
[15] Kario K, Saito I, Kushiro T, et al. Morning Home Blood Pressure Is a Strong Predictor of Coronary Artery Disease: The HONEST Study[J]. J Am Coll Cardiol, 2016, 67(13): 1519-1527.
[16] Doumas M, Tsioufis C, Fletcher R, et al. Time in therapeutic range, as a determinant of all-cause mortality in patients with hypertension[J]. J Am Heart Assoc, 2017, 6(11): e007131.
[17] Chung SC, Pujades-Rodriguez M, Duyx B, et al. Time spent at blood pressure target and the risk of death and cardiovascular diseases[J]. PLoS One, 2018, 13(9): e0202359.
